Molecular Markers of Chemotherapy Toxicity in Colorectal Cancer

被引：2
|
作者：
Braun, Michael S. [1 ]
Seymour, Matthew T. [1 ]
机构：
[1] Univ Leeds, Leeds Inst Mol Med, Sect Oncol & Clin Res, Leeds, W Yorkshire, England
来源：
CURRENT COLORECTAL CANCER REPORTS | 2011年 / 7卷 / 01期
关键词：
Fluorouracil; Irinotecan; Oxaliplatin; Pharmacogenomics; Toxicity; Colorectal;
D O I：
10.1007/s11888-010-0078-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Personalized medicine appears to be the inevitable consequence of improvements in our understanding of the mechanisms of action of chemotherapeutic agents, as well as the description of the human genome and its impact on our understanding of the genes involved in DNA repair and drug metabolism. These rapid developments have been associated with the first efforts to establish genetic predictors of chemotherapy efficacy and toxicity for the chemotherapy drugs active in colorectal cancer-fluorouracil, irinotecan, and oxaliplatin.
引用
收藏
页码：105 / 111
页数：7
相关论文
共 50 条
  • [21] Molecular markers of prognosis in colorectal cancer
    Nicholl, ID
    Dunlop, MG
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (15): : 1267 - 1269
  • [22] Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy
    Lassmann, Silke
    Tang, Laura
    Capanu, Marinela
    Brabletz, Thomas
    Schoepflin, Anja
    Hausen, Axel Zur
    Gonen, Mithat
    Kemeny, Nancy
    Shia, Jinru
    Klimstra, David
    Werner, Martin
    GASTROENTEROLOGY, 2007, 133 (06) : 1831 - 1839
  • [23] Capecitabine in palliative chemotherapy of colorectal cancer - efficacy and toxicity
    Stec, Rafal
    Bodnar, Lubomir
    Szczylik, Cezary
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2009, 13 (04): : 167 - 176
  • [24] Molecular markers and targets for colorectal cancer prevention
    Janakiram, Naveena B.
    Rao, Chinthalapally V.
    ACTA PHARMACOLOGICA SINICA, 2008, 29 (01) : 1 - 20
  • [25] Molecular markers and the future of colorectal cancer screening
    Carvalho, Beatriz
    Bosch, Linda J. W.
    Van Engeland, Manon
    Meijer, Gerrit A.
    COLORECTAL CANCER, 2013, 2 (02) : 95 - 97
  • [26] Molecular markers and targets for colorectal cancer prevention
    Naveena B Janakiram
    Chinthalapally V Rao
    Acta Pharmacologica Sinica, 2008, 29 : 1 - 20
  • [27] Fecal Molecular Markers for Colorectal Cancer Screening
    Kanthan, Rani
    Senger, Jenna-Lynn
    Kanthan, Selliah Chandra
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2012, 2012
  • [28] A Panel of Prognostic Molecular Markers in Colorectal Cancer
    Ivanov, K.
    Kolev, N.
    Tonev, A.
    Nikolova, G.
    Softova, E.
    PROCEEDINGS OF THE XXII BIENNIAL CONGRESS OF THE INTERNATIONAL SOCIETY OF UNIVERSITY COLON AND RECTAL SURGEONS - ISUCRS, 2008, : 51 - +
  • [29] Therapeutic relevance of molecular markers in colorectal cancer
    Noepel-Duennebacke, Stefanie
    Conradi, Lena-Christin
    Reinacher-Schick, Anke
    Ghadimi, Michael
    ONKOLOGE, 2020, 26 (08): : 685 - 697
  • [30] Important molecular genetic markers of colorectal cancer
    Kudryavtseva, Anna V.
    Lipatova, Anastasia V.
    Zaretsky, Andrew R.
    Moskalev, Alexey A.
    Fedorova, Maria S.
    Rasskazova, Anastasiya S.
    Shibukhova, Galina A.
    Snezhkina, Anastasiya V.
    Kaprin, Andrey D.
    Alekseev, Boris Y.
    Dmitriev, Alexey A.
    Krasnov, George S.
    ONCOTARGET, 2016, 7 (33) : 53959 - 53983
12345